137 related articles for article (PubMed ID: 38016198)
1. Multimodal spatiotemporal monitoring of basal stem cell-derived organoids reveals progression of olfactory dysfunction in Alzheimer's disease.
Liu M; Jiang N; Qin C; Xue Y; Wu J; Qiu Y; Yuan Q; Chen C; Huang L; Zhuang L; Wang P
Biosens Bioelectron; 2024 Feb; 246():115832. PubMed ID: 38016198
[TBL] [Abstract][Full Text] [Related]
2. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial vulnerability to oxidation in human brain organoids modelling Alzheimer's disease.
Holubiec MI; Alloatti M; Bianchelli J; Greloni F; Arnaiz C; Gonzalez Prinz M; Fernandez Bessone I; Pozo Devoto V; Falzone TL
Free Radic Biol Med; 2023 Nov; 208():394-401. PubMed ID: 37657763
[TBL] [Abstract][Full Text] [Related]
4. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders.
Fan W; Sun Y; Shi Z; Wang H; Deng J
Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155
[TBL] [Abstract][Full Text] [Related]
5. Neuronal network-based biomimetic chip for long-term detection of olfactory dysfunction model in early-stage Alzheimer's disease.
Liu M; Chen C; Gao K; Gao F; Qin C; Yuan Q; Zhang H; Zhuang L; Wang P
Biosens Bioelectron; 2022 Nov; 216():114619. PubMed ID: 35986984
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid ameliorates olfactory dysfunction in APP/PS1 transgenic mice of Alzheimer's disease: Ameliorations from the olfactory epithelium to the olfactory bulb.
Yao ZG; Jing HY; Wang DM; Lv BB; Li JM; Liu FF; Fan H; Sun XC; Qin YJ; Zhao MQ
Pharmacol Biochem Behav; 2016 May; 144():53-9. PubMed ID: 26948859
[TBL] [Abstract][Full Text] [Related]
7. [Development of an olfactory epithelial organoid culture system based on small molecule screening].
Wang H; Deng L; Qin X
Sheng Wu Gong Cheng Xue Bao; 2023 Jan; 39(1):318-336. PubMed ID: 36738219
[TBL] [Abstract][Full Text] [Related]
8. Modeling amyloid beta and tau pathology in human cerebral organoids.
Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
[TBL] [Abstract][Full Text] [Related]
9. Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease.
Saiz-Sanchez D; De La Rosa-Prieto C; Ubeda-Bañon I; Martinez-Marcos A
Anat Rec (Hoboken); 2013 Sep; 296(9):1413-23. PubMed ID: 23904197
[TBL] [Abstract][Full Text] [Related]
10. Olfactory dysfunction in the APP/PS1 transgenic mouse model of Alzheimer's disease: Morphological evaluations from the nose to the brain.
Yao ZG; Hua F; Zhang HZ; Li YY; Qin YJ
Neuropathology; 2017 Dec; 37(6):485-494. PubMed ID: 28643854
[TBL] [Abstract][Full Text] [Related]
11. Distinct amyloid precursor protein processing machineries of the olfactory system.
Kim JY; Rasheed A; Yoo SJ; Kim SY; Cho B; Son G; Yu SW; Chang KA; Suh YH; Moon C
Biochem Biophys Res Commun; 2018 Jan; 495(1):533-538. PubMed ID: 29097202
[TBL] [Abstract][Full Text] [Related]
12. Enhancing GABAergic signaling ameliorates aberrant gamma oscillations of olfactory bulb in AD mouse models.
Chen M; Chen Y; Huo Q; Wang L; Tan S; Misrani A; Jiang J; Chen J; Chen S; Zhang J; Tabassum S; Wang J; Chen X; Long C; Yang L
Mol Neurodegener; 2021 Mar; 16(1):14. PubMed ID: 33663578
[TBL] [Abstract][Full Text] [Related]
13. Notch Signaling Regulates Lgr5
Dai Q; Duan C; Ren W; Li F; Zheng Q; Wang L; Li W; Lu X; Ni W; Zhang Y; Chen Y; Wen T; Yu Y; Yu H
Stem Cells; 2018 Aug; 36(8):1259-1272. PubMed ID: 29664186
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β deposition and olfactory dysfunction in an Alzheimer's disease model.
Wu N; Rao X; Gao Y; Wang J; Xu F
J Alzheimers Dis; 2013; 37(4):699-712. PubMed ID: 23948910
[TBL] [Abstract][Full Text] [Related]
15. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
16. Pushing the boundaries of brain organoids to study Alzheimer's disease.
Cerneckis J; Bu G; Shi Y
Trends Mol Med; 2023 Aug; 29(8):659-672. PubMed ID: 37353408
[TBL] [Abstract][Full Text] [Related]
17. GABA
Hu B; Geng C; Guo F; Liu Y; Zong YC; Hou XY
Neurobiol Aging; 2021 Dec; 108():47-57. PubMed ID: 34507271
[TBL] [Abstract][Full Text] [Related]
18. Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure.
Chen X; Sun G; Tian E; Zhang M; Davtyan H; Beach TG; Reiman EM; Blurton-Jones M; Holtzman DM; Shi Y
Adv Sci (Weinh); 2021 Sep; 8(18):e2101462. PubMed ID: 34337898
[TBL] [Abstract][Full Text] [Related]
19. Olfactory neuropathology in Alzheimer's disease: a sign of ongoing neurodegeneration.
Son G; Jahanshahi A; Yoo SJ; Boonstra JT; Hopkins DA; Steinbusch HWM; Moon C
BMB Rep; 2021 Jun; 54(6):295-304. PubMed ID: 34162463
[TBL] [Abstract][Full Text] [Related]
20. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
